Frontiers in Oncology | Thoracic Oncology

Original Research

Published on 26 Nov 2021

Cost-Effectiveness Analysis of Pembrolizumab Plus Pemetrexed and Platinum Versus Chemotherapy Alone as First-Line Treatment in Metastatic Non-Squamous Non–Small Cell Lung Cancer: A Reconstruction of Partitioned Survival Model Based on Time Dependent Pricing Mechanism of Patient Assistance Program

in Thoracic Oncology

Yuanyi Cai
Wen Hui
Min Zhu
Mingyue Zhang
Zhixiang Gao
Huazhang Wu

Frontiers in Oncology

doi 10.3389/fonc.2021.768035

7,570 views
11 citations

Review

Published on 25 Nov 2021

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China

in Thoracic Oncology

Anwen Xiong
Jiali Wang
Caicun Zhou

Frontiers in Oncology

doi 10.3389/fonc.2021.757993

11,644 views
35 citations

Editorial

Published on 23 Nov 2021

Editorial: New Trends in Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: Clinical, Pathological and Molecular Aspects

in Thoracic Oncology

Kezhong Chen
Chen Chen

Frontiers in Oncology

doi 10.3389/fonc.2021.792252

2,647 views

Systematic Review

Published on 22 Nov 2021

Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review

in Thoracic Oncology

Ana Sofia Spencer
David da Silva Dias
Manuel Luís Capelas
Francisco Pimentel
Teresa Santos
Pedro Miguel Neves
Antti Mäkitie
Paula Ravasco

Frontiers in Oncology

doi 10.3389/fonc.2021.774081

19,836 views
18 citations

Original Research

Published on 19 Nov 2021

Biogeography of the Respiratory Tract Microbiome in Patients With Malignant Tracheal Tumors

in Thoracic Oncology

Kai-Xiong Liu
Hai-Xia Liu
Jing Zhang
Nan Zhang
Yun-Zhi Zhou
Mei-Mei Tao
Hong-Wu Wang
Jie-Ming Qu

Frontiers in Oncology

doi 10.3389/fonc.2021.758917

3,585 views
5 citations

Original Research

Published on 18 Nov 2021

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma

in Thoracic Oncology

Chengyin Weng
Lina Wang
Guolong Liu
Mingmei Guan
Lin Lu

Frontiers in Oncology

doi 10.3389/fonc.2021.763027

5,002 views
17 citations

Original Research

Published on 17 Nov 2021

Triglyceride-Glucose Index Is Not Associated With Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank

in Thoracic Oncology

Lijie Wang
Shucheng Si
Jiqing Li
Yunxia Li
Xiaolu Chen
Fuzhong Xue
Wangang Ren

Frontiers in Oncology

doi 10.3389/fonc.2021.774937

6,579 views
16 citations

Original Research

Published on 16 Nov 2021

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

in Thoracic Oncology

Jie Qian
Weimin Wang
Lin Wang
Jun Lu
Lele Zhang
Bo Zhang
Shuyuan Wang
Wei Nie
Yanwei Zhang
Yuqing Lou

Frontiers in Oncology

doi 10.3389/fonc.2021.745150

3,625 views
8 citations

Review

Published on 16 Nov 2021

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer

in Thoracic Oncology

Nathaniel Wiest
Umair Majeed
Karan Seegobin
Yujie Zhao
Yanyan Lou
Rami Manochakian

Frontiers in Oncology

doi 10.3389/fonc.2021.751209

10,323 views
26 citations

Correction

Published on 15 Nov 2021

Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

in Thoracic Oncology

Yuzhu Di
Yanan Jiang
Xiuyun Shen
Jing Liu
Yang Gao
Huimin Cai
Xiaoli Sun
Dandan Ning
Bing Liu
Jiaji Lei

Frontiers in Oncology

doi 10.3389/fonc.2021.785363

1,383 views

Original Research

Published on 11 Nov 2021

Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways

in Thoracic Oncology

Qiushi Wang
Chunhua Yan
Pengfei Zhang
Guanghua Li
Ruidong Zhu
Hanbing Wang
Libo Wu
Guangquan Xu

Frontiers in Oncology

doi 10.3389/fonc.2021.757541

3,618 views
11 citations

Review

Published on 11 Nov 2021

Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review

in Thoracic Oncology

Ben William Johnson
Ken Takahashi
Yuen Yee Cheng

Frontiers in Oncology

doi 10.3389/fonc.2021.748444

6,309 views
5 citations

Original Research

Published on 10 Nov 2021

Survival Outcomes of Local Compared With Systemic First Treatment of Non-Small Cell Lung Cancer Brain Metastases

in Thoracic Oncology

Hong-Mei Liu
Chun-Liu Meng
Lu-Jun Zhao

Frontiers in Oncology

doi 10.3389/fonc.2021.706409

4,280 views
2 citations

Original Research

Published on 10 Nov 2021

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients

in Thoracic Oncology

Olga V. Pankova
Liubov A. Tashireva
Evgeny O. Rodionov
Sergey V. Miller
Sergey A. Tuzikov
Dmitry S. Pismenny
Tatiana S. Gerashchenko
Marina V. Zavyalova
Sergey V. Vtorushin
Evgeny V. Denisov

Frontiers in Oncology

doi 10.3389/fonc.2021.771802

3,225 views
8 citations

Systematic Review

Published on 08 Nov 2021

Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

in Thoracic Oncology

Ling Peng
Dafeng Lu
Yang Xia
Shaodong Hong
Giovanni Selvaggi
Justin Stebbing
Yilan Sun
Fei Liang

Frontiers in Oncology

doi 10.3389/fonc.2021.754768

10,340 views
22 citations

Original Research

Published on 08 Nov 2021

Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study

in Thoracic Oncology

Toshiki Ogiwara
Hitoshi Kawazoe
Saeka Egami
Hironobu Hashimoto
Yoshimasa Saito
Naomi Sakiyama
Yuichiro Ohe
Masakazu Yamaguchi
Tetsuya Furukawa
Azusa Hara

Frontiers in Oncology

doi 10.3389/fonc.2021.770268

3,804 views
4 citations

Original Research

Published on 03 Nov 2021

Intertumoural Heterogeneity and Branch Evolution of Synchronous Multiple Primary Lung Adenocarcinomas by Next-Generation Sequencing Analysis

in Thoracic Oncology

Qinleng Zhang
Hui Jia
Zhendan Wang
Shaoyu Hao
Haiyan Huang
Airong Yang
Lu Han
Pingping Song

Frontiers in Oncology

doi 10.3389/fonc.2021.760715

3,223 views
4 citations

Review

Published on 02 Nov 2021

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions

in Thoracic Oncology

Cristina Mantovani
Alessio Gastino
Marzia Cerrato
Serena Badellino
Umberto Ricardi
Mario Levis

Frontiers in Oncology

doi 10.3389/fonc.2021.772789

14,464 views
44 citations

Original Research

Published on 01 Nov 2021

Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients

in Thoracic Oncology

Neda K. Dezfuli
Shamila D. Alipoor
Neda Dalil Roofchayee
Sharareh Seyfi
Babak Salimi
Ian M. Adcock
Esmaeil Mortaz

Frontiers in Oncology

doi 10.3389/fonc.2021.715677

6,535 views
26 citations

Original Research

Published on 28 Oct 2021

Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor

in Thoracic Oncology

Xiaodong Yuan
Lei Huang
Wenwu Luo
Yufei Zhao
Björn Nashan
Fazhi Yu
Yun Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.708735

7,350 views
24 citations

Original Research

Published on 26 Oct 2021

Suction Versus Nonsuction Drainage After Uniportal Video-Assisted Thoracoscopic Surgery: A Propensity Score-Matched Study

in Thoracic Oncology

Jian Zhou
Chuan Li
Quan Zheng
Chenglin Guo
Mengyuan Lyu
Qiang Pu
Hu Liao
Lunxu Liu

Frontiers in Oncology

doi 10.3389/fonc.2021.751396

3,669 views
6 citations

Original Research

Published on 22 Oct 2021

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma

in Thoracic Oncology

Wangyang Meng
Han Xiao
Rong Zhao
Dong Li
Kuo Li
Yunchong Meng
Jiaping Chen
Yangwei Wang
Yongde Liao

Frontiers in Oncology

doi 10.3389/fonc.2021.608239

4,633 views
6 citations

Review

Published on 21 Oct 2021

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers

in Thoracic Oncology

Kasey R. Cargill
William L. Hasken
Carl M. Gay
Lauren A. Byers

Frontiers in Oncology

doi 10.3389/fonc.2021.757323

7,053 views
15 citations

Original Research

Published on 20 Oct 2021

SPTBN2, a New Biomarker of Lung Adenocarcinoma

in Thoracic Oncology

Chunli Wu
Bo Dong
Lan Huang
Yafei Liu
Guanchao Ye
Shihao Li
Yu Qi

Frontiers in Oncology

doi 10.3389/fonc.2021.754290

6,760 views
14 citations

1,969 articles

articles

Cost-Effectiveness Analysis of Pembrolizumab Plus Pemetrexed and Platinum Versus Chemotherapy Alone as First-Line Treatment in Metastatic Non-Squamous Non–Small Cell Lung Cancer: A Reconstruction of Partitioned Survival Model Based on Time Dependent Pricing Mechanism of Patient Assistance Program

Immunotherapy in the First-Line Treatment of NSCLC: Current Status and Future Directions in China

Editorial: New Trends in Early-Stage Lung Cancer Presenting as Ground-Glass Opacities: Clinical, Pathological and Molecular Aspects

Managing Severe Dysgeusia and Dysosmia in Lung Cancer Patients: A Systematic Scoping Review

Biogeography of the Respiratory Tract Microbiome in Patients With Malignant Tracheal Tumors

Identification of a N6-Methyladenosine (m6A)-Related lncRNA Signature for Predicting the Prognosis and Immune Landscape of Lung Squamous Cell Carcinoma

Triglyceride-Glucose Index Is Not Associated With Lung Cancer Risk: A Prospective Cohort Study in the UK Biobank

The Survival Benefit for Optimal Glycemic Control in Advanced Non-Small Cell Lung Cancer Patients With Preexisting Diabetes Mellitus

Role of Immune Checkpoint Inhibitor Therapy in Advanced EGFR-Mutant Non-Small Cell Lung Cancer

Corrigendum: Downregulation of miR-135b-5p Suppresses Progression of Esophageal Cancer and Contributes to the Effect of Cisplatin

Microarray Identifies a Key Carcinogenic Circular RNA 0008594 That Is Related to Non-Small-Cell Lung Cancer Development and Lymph Node Metastasis and Promotes NSCLC Progression by Regulating the miR-760-Mediated PI3K/AKT and MEK/ERK Pathways

Preclinical Models and Resources to Facilitate Basic Science Research on Malignant Mesothelioma – A Review

Survival Outcomes of Local Compared With Systemic First Treatment of Non-Small Cell Lung Cancer Brain Metastases

Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients

Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis

Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study

Intertumoural Heterogeneity and Branch Evolution of Synchronous Multiple Primary Lung Adenocarcinomas by Next-Generation Sequencing Analysis

Modern Radiation Therapy for the Management of Brain Metastases From Non-Small Cell Lung Cancer: Current Approaches and Future Directions

Evaluation Expression of miR-146a and miR-155 in Non-Small-Cell Lung Cancer Patients

Diagnostic and Prognostic Significances of SOX9 in Thymic Epithelial Tumor

Suction Versus Nonsuction Drainage After Uniportal Video-Assisted Thoracoscopic Surgery: A Propensity Score-Matched Study

The Prognostic Value of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers

SPTBN2, a New Biomarker of Lung Adenocarcinoma